Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Oral Health

In brief

The purpose of this study is to determine if an oral probiotic tablet taken once a day for twelve weeks can decrease the numbers of bacteria that are associated with tooth decay and gum disease in a dentally healthy, young adult population.

Key facts

Study ID

NCT01520974

Run by

Oragenics, Inc.

People needed

48

Starts

2012-01-01

Last updated by the study team

2012-05-02

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• minimum of 20 teeth, with only a few fillings
• good general health
• willing to use an appropriate method of birth control during the study
• measurable levels of Streptococcus mutans and one or more of the selected periodontal pathogens

You may not qualify if…

• chronic or acute illness such as heart disease, diabetes, cancer, hepatitis (liver disease) or HIV positive
• radiation therapy or systemic cancer treatment (chemotherapy)
• require antibiotics for dental treatment
• pregnant or planning to become pregnant during the study period

Where it is running

• University of Washington, Scool of Dentistry, Regional Clinical Dental Research Center — Seattle, Washington, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.